Back to Search

KRISTEN KESTER, MD, MPH

MD, MPH

Pediatric Emergency Medicine (Pediatrics) Physician

NPI: 1518356294Individual

Specialties, Licenses & Credentials

Pediatric Emergency Medicine (Pediatrics) PhysicianPrimary

Pediatrics — Pediatric Emergency Medicine

Code: 2080P0204X

036.152555(IL)

Research & Publications (20)

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.
PMID 19569965·J Infect Dis·2009
3-trial
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research.
PMID 18387719·Vaccine·2008
3-trial
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.
PMID 17574311·Vaccine·2007
3-trial
Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.
PMID 11170991·J Infect Dis·2001
3-trial
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
PMID 19649245·PLoS One·2009
3-trial
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
PMID 19390585·PLoS One·2009
3-trial
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia.
PMID 19276646·Hum Vaccin·2009
4-observational
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.
PMID 18455276·Vaccine·2008
7-preclinical
Characterization of human DNA in environmental samples.
PMID 18420364·Forensic Sci Int·2008
8-other
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
PMID 16388879·Vaccine·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
225 E CHICAGO AVE
CHICAGO, IL 60611

Quick Facts

NPI
1518356294
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile